A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases.
Fan Y, Arechederra M, Richelme S, Daian F, Novello C, Calderaro J, Di Tommaso L, Morcrette G, Rebouissou S, Donadon M, Morenghi E, Zucman-Rossi J, Roncalli M, Dono R, Maina F.
Fan Y, et al. Among authors: di tommaso l.
Hepatology. 2017 Nov;66(5):1644-1661. doi: 10.1002/hep.29304. Epub 2017 Sep 29.
Hepatology. 2017.
PMID: 28586114